Viewing Study NCT01620060


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-06-25 @ 3:13 PM
Study NCT ID: NCT01620060
Status: COMPLETED
Last Update Posted: 2016-04-08
First Post: 2012-05-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Lurasidone Pediatric Pharmacokinetics Study
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
None Autism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None autism View
None bipolar View
None Lurasidone View
None Latuda View